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Abstract
Synthesis of the C1-C6 and C7-C23 fragments of the proposed structure of iriomoteolide 1a has
been accomplished. Key steps include a cross metathesis to form the C15-C16 E olefin and a
chelation controlled Grignard addition to form the tertiary alcohol at C14. Notably, 7 of the 9
stereocenters of the proposed structure have been set using various aldol reactions employing
metallo enolates of thiazolidinethiones.
In 2007, Tsuda and coworkers isolated a novel macrolide from the dinoflagellate sp.
Amphdinium strain HYA024, identified as iriomoteolide 1a (1).1 The natural product
exhibits potent cytotoxicity against the human B lymphocyte DG-75 cells (IC50 = 0.002 mg/
mL), which is 20 times more potent than doxorubicin (IC50 = 0.04 mg/mL), a common
chemotherapy agent.1 Additionally, iriomoteolide 1a also displays activity against Epstein-
Barr virus (EBV) infected human B-lymphocyte Raji cells (IC50 = 0.003 mg/mL).1 Because
of the attractive biological profile and the unique structural attributes of iriomoteolide 1a,
several laboratories have undertaken the total synthesis of 1. The groups of Loh,2 Paterson,3
Zhao,4 Li,5 and Dai6 have reported creative approaches to complex fragments of 1, while
Horne,7 Ghosh,8 and Yang9 have completed the total synthesis of macrolactone 1. During
the course of their synthetic studies, Horne,7 Ghosh,8 and Yang9 independently ascertained
that the proposed structure of iriomoteolide 1a had been misassigned.
Our interest in the total synthesis of iriomoteolide 1a stems from the inherent ability of the
thiazolidinethione chiral auxiliary to access all possible polyketide subunits using simple
variations of aldol reaction conditions. Once a convergent route to the proposed structure is
developed, appropriate diastereomers can be rapidly prepared in a highly convergent fashion
in an effort to elucidate the actual structure of the natural product. The retrosynthetic
analysis is shown in Figure 2. It was envisioned that iriomoteolide 1a would arise via a late
stage Yamaguchi esterification10 between acid 2 and secondary alcohol 3 followed by a ring
closing metathesis to construct the C6-C7 alkene and install the macrocyclic ring of 1. A
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cross metathesis of enone 4 with PMB ether 5 would form the C15-C16 E olefin, while a
nonselective aldol between a C12-C23 methyl ketone and aldehyde 6 would assemble the
C11-C12 bond.
Preparation of the C16-C23 PMB ether 5 commenced with an Evans syn aldol with
thioimide 7 and acetaldehyde to provide the secondary alcohol 8 in 80% yield and 20:1 dr
(Scheme 1).11 Protection of the secondary alcohol as the TIPS ether and cleavage of the
chiral auxiliary delivered a primary alcohol, which underwent a one-carbon homologation
by first transforming the primary alcohol into mesylate 9 followed by stirring with KCN.
Isolation of the nitrile proved difficult, so the crude mixture was reduced directly with i-
Bu2AlH, to provide aldehyde 10. Aldehyde 10 was then subjected to a second Evans syn
aldol with thioimide 11, generating secondary alcohol 12 in 86% and >20:1 dr.12 Reductive
cleavage of the chiral auxiliary with LiBH4 provided a diol, which cleanly underwent an
acetal formation-reduction sequence to regioselectively mask the secondary alcohol as PMB
ether 13. Exposure of the resultant primary alcohol to mesyl chloride followed by LiEt3BH
reduction generated PMB ether 5 in 12 steps and 18% overall yield.
The C12-C15 fragment was synthesized beginning with commercially available (S)-ethyl
lactate, which was transformed in two steps via a known procedure to the benzyl protected
Weinreb amide 14 (Scheme 2).13 Exposure of Weinreb amide 14 to excess vinyl Grignard
reagent provided 4 (Figure 2), which was utilized in a cross metathesis with PMB ether 5 to
deliver exclusive formation of the E isomer 15 in 67% yield over 2 steps. A chelation-
controlled addition of methyl magnesium bromide to ketone 15 provided the tertiary alcohol
16 as the only detectable diastereomer after reductive cleavage of the benzyl ether with
lithium 4,4-di-t-butylbiphenylide (LDBB).14 Oxidation of the secondary alcohol to the
ketone under Parikh-Doering conditions15 produced the ketone 17a. Protection of the
tertiary alcohol as its TBS ether provided the C12-C23 fragment 17b. The stereochemistry
of the tertiary alcohol at C14 was deduced by forming the 5-membered acetonide 18 from
diol 16 (Scheme 3). The C14 stereochemistry was assigned as (R) based on observed
NOESY correlation between the C13 hydrogen and C14 methyl group as well as C15
hydrogen and the C13 methyl group.
With ketone fragment 17a in hand, attention turned to preparation of aldehyde 6. Beginning
with an acetate aldol utilizing mesityl substituted thiazolidinethione 1916 and 3-butenal,17
secondary alcohol 20 was generated in 70% yield and >20:1 dr (Scheme 4). Protection of the
resulting secondary alcohol as the TES ether, and reductive cleavage of the chiral auxiliary
furnished aldehyde 6. A nonselective aldol between ketone 17a and aldehyde 6 delivered the
secondary alcohol as an inconsequential ca. 1:1 mixture of diastereomers at C11.
Cleavage of the TES ether and spontaneous ketalization to form a mixed methyl ketal was
accomplished under mild conditions utilizing catalytic triphenyl phosphonium
hydrobromide salt to deliver an unstable mixed methyl ketal.18 The resultant alcohol was
used directly in the subsequent Ley oxidation19 to afford ketone 21. The C11 exocyclic
methylene proved challenging to install: attempts to install the C11 exocyclic olefin under
standard methylenation conditions (Wittig, Tebbe,20 Tour,21 Takai-Nozaki22) in the
presence of the free tertiary alcohol at C14 (21) resulted in either elimination or no reaction,
likely due to the presence of the free alcohol at C14. Attempts to protect the free alcohol of
21 directly with TESOTf, TMSOTf, or TMSCl resulted in formation of the C11 mixed silyl
ketal, wherein the silyl triflate or silyl chloride behaved as Lewis acids due to the crowded
steric environment, rather than silylating agents as in similar systems.23 Fortunately, the C14
tertiary alcohol of 17a could be protected as the TBS ether prior to the aldol addition to form
17b. Aldol reaction of ketone 17b and aldehyde 6 followed by treatment as before generated
mixed ketal 22. The exocyclic methylene was then successfully installed in 77% yield
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employing the Tebbe reagent.20 Cleavage of the PMB ether was accomplished with DDQ,
which also cleaved the mixed methyl ketal to deliver hemiketal 3.
Synthesis of the C1-C6 fragment 2 began with a known Evans anti aldol with thioimide 23
and cinnamaldehyde24 followed by a Hoveyda-Grubbs catalyzed ethylene cross metathesis
to install terminal olefin 24 (Scheme 5). Protection of the secondary alcohol as the TBS
ether and cleavage of the chiral auxiliary afforded aldehyde 25, which was subjected to a
Corey-Fuchs homologation25 to deliver ynoate 26. Methyl cuprate addition was used to
form enoate 27, and the olefin geometry was confirmed by observed NOESY correlations
between the C2 hydrogen and C3 methyl group. Cleavage of the methyl ester to the acid was
accomplished with LiOH and MeOH to provide acid 2 in 63% yield over 2 steps.
Completion of the synthesis of 1 would require esterification of acid 2 with alcohol 3,
protection of the silyl ethers followed by RCM to generate the proposed structure of
iriomoteolide 1a, in a similar strategy to that employed by Horne.7
In summary, a concise and convergent approach to the proposed structure of iriomoteolide
1a has been developed. Key steps include a cross metathesis to form the C15-C16 bond, and
an acetate aldol to form the C21-C-22 bond. The thiazolidinethione chiral auxiliary was
exploited to create 7 of the 9 stereocenters of iriomoteolide 1a through various aldol
additions. Importantly, simple changes in the reagents utilized in these aldol additions can
facilitate access to other possible stereoisomers. Since the proposed structure of the natural
product has been incorrectly assigned, our current efforts are directed toward utilizing our
approach to prepare diastereomers of the reported structure in an effort to elucidate the
correct structure of the natural product.
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Iriomoteolide 1a proposed structure.
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Retrosynthetic analysis of iriomoteolide 1a.
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Preparation of the C16-C23 fragment of iriomoteolide 1a.
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Synthesis of the C12-C23 fragment 17.
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Stereochemical proof for the absolute stereochemistry of the C14 tertiary alcohol.
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Preparation of the C7-C23 fragment 3.
Crimmins and Dechert Page 10














Preparation of the C1-C6 fragment 2 and proposed completion of 1.
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